超分子组件在药物输送和光动力疗法中的应用
Kharu Nisa1, Ishfaq Ahmad Lone1, Waseem Arif1
1Department of Chemistry, Material Chemistry Laboratory, National Institute of Technology Srinagar 190006 India nylabhat.bn@gmail.com rkuhp05@gmail.com.
RSC medicinal chemistry
|December 18, 2023
概括
光动力疗法 (PDT) 使用光敏剂 (PSs) 选择性地破坏癌细胞. 新型超分子组件提供了改进的PSS,用于更有效的癌症治疗,副作用更少.
科学领域:
- 超分子化学 超分子化学
- 纳米技术纳米技术
- 摄影化学的使用.
背景情况:
- 癌症仍然是一个重大的全球健康挑战.
- 传统的抗癌药物可以损害正常组织.
- 光动力疗法 (PDT) 为癌症治疗提供了一种有针对性的方法.
研究的目的:
- 探索用于增强光动力学治疗 (PDT) 的先进光敏化剂 (PSs) 的开发.
- 研究超分子组件作为PDT剂的新平台.
- 为了提高癌症治疗的疗效和减少癌症治疗的副作用.
主要方法:
- 利用宿主-客人相互作用来创建纳米基因和其他超分子组件.
- 设计功能化的分子,以提高光敏剂的性能.
- 研究基于氨酸的高分子组件用于生物成像和PDT.
主要成果:
- 基于纳米基因和其他支架的超分子组件提供了更简单的合成和净化.
- 非共价相互作用使可控制的光活性,提高PDT的有效性.
- 氨酸超分子组件在PDT和生物成像中显示出高效的电子转移和光的前景.
结论:
- 超分子组件是开发PDT下一代光敏感剂的一个有希望的策略.
- 这些组件的多功能化可以导致高效的向癌症疗法.
- 预计功能化的超分子组件的进一步开发将大大提高癌症治疗的可能性.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


